[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"stock-detail-DMRA":3,"homepage-market-summary":31,"stock-news-DMRA":173},{"ticker":4,"date":5,"profile":6,"dividend":9,"quote":15},"DMRA","2026-10-02",{"name":7,"exchange":8,"sector":9,"industry":10,"description":11,"ceo":9,"employees":12,"headquarters":13,"founded":9,"is_fund":14,"issuer":9,"category":9},"Damora Therapeutics, Inc. Ordinary Shares","Nasdaq",null,"PHARMACEUTICAL PREPARATIONS","Damora Therapeutics Inc is a biotechnology company that aims to fundamentally redefine care for people with hematologic disorders. The group is advancing a new generation of biologics to treat mutant calreticulin-driven myeloproliferative neoplasms, including essential thrombocythemia and myelofibrosis, where there is cruicial medical need for disease-modifying treatments. Its goal is to rapidly bring forward optimized therapies with broad mutation coverage and exceptional convenience to dramatically improve patient outcomes. The group's pipeline products are DMR-001, DMR-002, DMR-003, and GB3226.","7","Waltham, MA",false,{"close":16,"open":17,"high":18,"low":19,"prev_close":20,"change":21,"percent_change":22,"volume":23,"transactions":24,"vwap":25,"high_52w":26,"low_52w":27,"avg_volume_52w":28,"range_52w_percent":29,"record_count":30},20.65,20.55,20.765,19.59,20.23,0.42,2.08,692098.108286,9992,20.185,38.325,3.64,982797.088623964,49,1488,{"status":32,"indices":33,"watchlist":77,"sectors":99,"benchmarks":155},"success",[34,42,49,56,63,70],{"symbol":35,"name":36,"price":37,"change":38,"pct_change":39,"is_up":40,"sparkline":41,"date":5},"SPX","S&P 500",7722.72,56.27,0.73,true,"0.0,5.0 2.3,8.0 4.6,10.4 6.9,13.4 9.3,9.1 11.6,11.5 13.9,13.8 16.2,16.0 18.5,10.3 20.8,9.5 23.2,2.0 25.5,2.0 27.8,5.9 30.1,6.0 32.4,3.4 34.7,7.3 37.1,8.2 39.4,9.4 41.7,8.5 44.0,4.8",{"symbol":43,"name":44,"price":45,"change":46,"pct_change":47,"is_up":40,"sparkline":48,"date":5},"NDX","NASDAQ 100",30807.93,306.37,1,"0.0,11.5 2.3,11.7 4.6,12.4 6.9,14.8 9.3,12.8 11.6,14.6 13.9,16.0 16.2,15.9 18.5,12.2 20.8,10.7 23.2,4.4 25.5,2.6 27.8,4.5 30.1,4.5 32.4,3.5 34.7,6.0 37.1,5.5 39.4,5.0 41.7,4.3 44.0,2.0",{"symbol":50,"name":51,"price":52,"change":53,"pct_change":54,"is_up":40,"sparkline":55,"date":5},"DJI","DOW JONES",51177,250,0.49,"0.0,2.0 2.3,5.5 4.6,7.8 6.9,9.5 9.3,6.7 11.6,7.5 13.9,9.4 16.2,12.9 18.5,11.1 20.8,11.7 23.2,9.6 25.5,10.7 27.8,12.6 30.1,13.5 32.4,10.8 34.7,12.8 37.1,13.5 39.4,16.0 41.7,15.9 44.0,14.5",{"symbol":57,"name":58,"price":59,"change":60,"pct_change":61,"is_up":40,"sparkline":62,"date":5},"COMP","NASDAQ Composite",27190.86,319.27,1.19,"0.0,10.2 2.3,11.1 4.6,13.0 6.9,14.9 9.3,12.1 11.6,13.7 13.9,16.0 16.2,16.0 18.5,11.1 20.8,10.0 23.2,3.4 25.5,2.0 27.8,5.4 30.1,5.4 32.4,3.9 34.7,6.7 37.1,6.9 39.4,6.2 41.7,6.1 44.0,2.6",{"symbol":64,"name":65,"price":66,"change":67,"pct_change":68,"is_up":40,"sparkline":69,"date":5},"RUT","RUSSELL 2000",2815.2,25,0.9,"0.0,2.0 2.3,3.0 4.6,6.1 6.9,8.4 9.3,7.5 11.6,8.8 13.9,10.4 16.2,11.3 18.5,10.2 20.8,11.2 23.2,10.1 25.5,8.8 27.8,12.9 30.1,13.1 32.4,12.8 34.7,14.4 37.1,15.1 39.4,16.0 41.7,15.1 44.0,13.2",{"symbol":71,"name":72,"price":73,"change":74,"pct_change":75,"is_up":14,"sparkline":76,"date":5},"VIX","CBOE VIX",15.31,-1.08,-6.59,"0.0,14.8 2.3,10.2 4.6,7.3 6.9,2.0 9.3,9.7 11.6,4.9 13.9,4.5 16.2,2.5 18.5,11.3 20.8,13.7 23.2,13.5 25.5,16.0 27.8,12.3 30.1,10.4 32.4,13.5 34.7,8.8 37.1,8.9 39.4,7.8 41.7,7.6 44.0,11.8",[78,85,92],{"symbol":79,"name":80,"price":81,"change":82,"pct_change":83,"is_up":40,"sparkline":84,"date":5},"NVDA","NVIDIA Corp",233.95,3.09,1.34,"0.0,16.0 7.3,15.3 14.7,9.6 22.0,12.1 29.3,10.3 36.7,6.6 44.0,2.0",{"symbol":86,"name":87,"price":88,"change":89,"pct_change":90,"is_up":40,"sparkline":91,"date":5},"AAPL","Apple Inc",333.69,3.37,1.02,"0.0,8.2 7.3,2.0 14.7,5.2 22.0,16.0 29.3,11.7 36.7,14.9 44.0,10.9",{"symbol":93,"name":94,"price":95,"change":96,"pct_change":97,"is_up":40,"sparkline":98,"date":5},"TSLA","Tesla Inc",370.59,16.48,4.65,"0.0,2.0 7.3,5.3 14.7,13.4 22.0,16.0 29.3,14.9 36.7,15.3 44.0,6.1",[100,105,110,115,120,125,130,135,140,145,150],{"name":101,"etf":102,"change":103,"price":104,"is_up":40},"Technology","XLK",1.01,199.81,{"name":106,"etf":107,"change":108,"price":109,"is_up":40},"Financials","XLF",0.06,53.49,{"name":111,"etf":112,"change":113,"price":114,"is_up":14},"Healthcare","XLV",-0.01,166.18,{"name":116,"etf":117,"change":118,"price":119,"is_up":40},"Consumer Cycl","XLY",1.13,110.04,{"name":121,"etf":122,"change":123,"price":124,"is_up":40},"Consumer Staples","XLP",0.25,80.53,{"name":126,"etf":127,"change":128,"price":129,"is_up":40},"Energy","XLE",0.4,62.95,{"name":131,"etf":132,"change":133,"price":134,"is_up":40},"Industrials","XLI",0.78,169.95,{"name":136,"etf":137,"change":138,"price":139,"is_up":40},"Materials","XLB",0.66,48.86,{"name":141,"etf":142,"change":143,"price":144,"is_up":40},"Real Estate","XLRE",0.32,40.81,{"name":146,"etf":147,"change":148,"price":149,"is_up":40},"Utilities","XLU",0.38,39.83,{"name":151,"etf":152,"change":153,"price":154,"is_up":40},"Comm Services","XLC",0.35,110.32,[156,161,165,169],{"ticker":157,"name":158,"price":159,"change":160,"is_up":40},"SPY","SPDR S&P 500 ETF",769.64,0.74,{"ticker":162,"name":163,"price":164,"change":90,"is_up":40},"QQQ","Invesco QQQ Trust",749.58,{"ticker":166,"name":167,"price":168,"change":54,"is_up":40},"DIA","SPDR Dow Jones ETF",511.1,{"ticker":170,"name":171,"price":172,"change":68,"is_up":40},"IWM","iShares Russell 2000",281.52,{"ticker":4,"count":174,"articles":175},11,[176,182,188,194,200,206,212,218,224,229,235],{"title":177,"link":178,"pubDate":179,"description":180,"source":181},"Using personal funds, CEO Jennifer Jarrett buys Damora Therapeutics (DMRA) shares at $20.23 each. - Stock Titan","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiuAFBVV95cUxQVzdONUFXWk5EeHNsWHBOdE9uV2xLQlNIWk9mM2REcnVQb19QcXMwVVlIRzJBSFBjVDFwTmhIa0hyQUoxbjBWWDY5c1NFc0lLVnJ6Rm9sbUFMcGhyLUd4ajhkTjhJTWxZaGt1WEVfZzRFMDJQcHFIN3A2dHlpaTlNREZKX19ZbFp1cXdwU0ZlMHhkMGtGb1JoSFZhRGlHZkRKMm5COHFscUEybzZwbm8xTlNZcWluU2Fh?oc=5","Mon, 28 Sep 2026 11:00:43 GMT","Using personal funds, CEO Jennifer Jarrett buys Damora Therapeutics (DMRA) shares at $20.23 each. Stock Titan","Stock Titan",{"title":183,"link":184,"pubDate":185,"description":186,"source":187},"Insider Stock Purchases: September 28, 2026 - Quiver Quantitative","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMihwFBVV95cUxPNzd2WGNOa015S0h6MkRPMmVZZ0Z3ZExNeDctR0dWY1hYZlhsTjlVWi1sU19DLU0wMG9la1JqQWF3NmFWVW1PbTBrVWhkM0ZvU2psSHFJaWgwUERhNXk4MlNldWNTT1RuQWd1cVBLQUVKTmVoT3BONjJ1Wl9OX1pXS2Z5OERieVk?oc=5","Mon, 28 Sep 2026 18:45:00 GMT","Insider Stock Purchases: September 28, 2026 Quiver Quantitative","Quiver Quantitative",{"title":189,"link":190,"pubDate":191,"description":192,"source":193},"DMRA Reiterates by Wedbush -- Price Target Maintained at $40 - GuruFocus","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMimwFBVV95cUxPX28zQmRjRVB0ZkdKcE50NW45WUlIR0poX0UxN294SmVzX0JxdFZhcWdLcWJiTXJXaUxsSjBZYnZlQUJKQ2Z3TDUtamhGUXJxSUhNeHNFaVA5T1RLSmd5RTY0SWVaMThkZFdTLVdyWFR5Ql9VeEpfbW0xdTFDT3NoNjczc3hBdzBURXc5U25rTHJNai1oVFB5S0E2RQ?oc=5","Tue, 29 Sep 2026 13:03:31 GMT","DMRA Reiterates by Wedbush -- Price Target Maintained at $40 GuruFocus","GuruFocus",{"title":195,"link":196,"pubDate":197,"description":198,"source":199},"(DMRA) Movement Within Algorithmic Entry Frameworks - news.stocktradersdaily.com","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiyAFBVV95cUxQZmQ4aEZyREhkYVU5MnNjZzh1c1d0LWJvXzlYWWpyZGtxaEREdkJQQ3AwRVRuV0loU0ZLa0V0YnpBVDBVQW1ZMVE4a0JnX2FLdU1aT1VGM09JZXREbnhDOC13ekw2dHJoRkN6NkZicS1NbHhEVTJZMWRydGNGdE9McTM5eTJOMzZlUTdnclhhOFFPRHZyQTNfX2JwbUhnWHlWYm12aHlOVGNXbEg3azIxNTZSSk1vU1NhOGF1R21hUFQzYlpTczYybA?oc=5","Sun, 27 Sep 2026 15:18:02 GMT","(DMRA) Movement Within Algorithmic Entry Frameworks news.stocktradersdaily.com","news.stocktradersdaily.com",{"title":201,"link":202,"pubDate":203,"description":204,"source":205},"CEO, President & Director of Damora Therapeutics Picks Up 2.5% More Stock - Simply Wall Street","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\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?oc=5","Wed, 30 Sep 2026 10:17:42 GMT","CEO, President & Director of Damora Therapeutics Picks Up 2.5% More Stock Simply Wall Street","Simply Wall Street",{"title":207,"link":208,"pubDate":209,"description":210,"source":211},"Guggenheim raises Damora Therapeutics price target on MF sales outlook - Investing.com","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiygFBVV95cUxQRkxuSy13Y0F5Y1d0ZkRUZlczeWxzQ3RST01fRFJJb0JWX2FtNU5WV0R5MW5MTm55T1RiT0hBMDJqLVpEVDhNaFFrUnItY0JaMXFVU3gxLXA4ZUdGcTdpYk00M1JYZHZxM1NLLXlBdUlVVVNXYWYxQkxEcFlHU1NXdU1ubTExNW9NX3hSMnNOYXM2UVI4d1B0QXdRY1A4NzdYMFI4bHNGWE1LUG1RdW1XWm4yeXoyRkhfczQxLUNicmtSdHBjbkJUdldR?oc=5","Fri, 25 Sep 2026 11:30:56 GMT","Guggenheim raises Damora Therapeutics price target on MF sales outlook Investing.com","Investing.com",{"title":213,"link":214,"pubDate":215,"description":216,"source":217},"Breaking News about Damora Therapeutics, Inc. - Ordinary Shares (Nasdaq:DMRA) - FinancialContent","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiYEFVX3lxTFBKRmVGa1pOWFE0dDZuTlU0UjQ5Uk9vSTY5R2lCcVlJNkFlT2puSEtWZWdxaTNLdzJIczllUDhMOEFqTTVhV0d4bEhMYjc2WWx3ek9rbWdzVDc0X1R5ME9NQQ?oc=5","Fri, 02 Oct 2026 17:04:00 GMT","Breaking News about Damora Therapeutics, Inc. - Ordinary Shares (Nasdaq:DMRA) FinancialContent","FinancialContent",{"title":219,"link":220,"pubDate":221,"description":222,"source":223},"Damora Therapeutics Insider Bought Shares Worth $252,875, According to a Recent SEC Filing - marketscreener.com","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMi2AFBVV95cUxNNzVwM0YtS3JwV3IxVWtzM0ZqQkk3dTJzM21aT3lvU0ZIRUhxdUFhcnlxWlE5SzZwTTFNS0lFLVZqOG5SdUdLWjgxVmp3V0xEcTAxRVVydjE3bmZiOXBUamRKNzNlOTBPNmhxWGhVLUJCQkJXS3BrU0M1NVU5Z0FmMUNYZlZjYmYtWkMtbUFoenZOZmJZNGdvR0VvWnVONzJsN01LbW5jODhDRXRuTHFRN3N4UzB4bms3VV9qMXQ1SVNRbDlTMGc2b3FldWtwYTBJYU8ya05tTTI?oc=5","Mon, 28 Sep 2026 11:35:36 GMT","Damora Therapeutics Insider Bought Shares Worth $252,875, According to a Recent SEC Filing marketscreener.com","marketscreener.com",{"title":225,"link":226,"pubDate":227,"description":228,"source":193},"Damora Therapeutics (DMRA) CEO Jennifer Jarrett Buys 12,500 Shar - GuruFocus","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiwwFBVV95cUxQcUMxNElhdm1KWUNnM05SWUQ0bkUyWlE2Q190TWFYWENSUXZZa0JSMzVaQVk3eUpfRGFzUXAyeUhJQ2wxT2tURWNmYzluTzZsMEF1dmZmVklqNktoUWVNa0s4Tm1FZmF6eFd6VkRoMm00Y093bHFBbkNyVmZzVXJOYjlFYTNISmVnd3RVNDBWWl9UWmE0bXdSRUFBZnZ5R2lFOTQwdEppYnpBeEpkQlBjQ2Y4M0lWZjBMVnFBVUZFZjJpalE?oc=5","Mon, 28 Sep 2026 12:44:42 GMT","Damora Therapeutics (DMRA) CEO Jennifer Jarrett Buys 12,500 Shar GuruFocus",{"title":230,"link":231,"pubDate":232,"description":233,"source":234},"Damora Therapeutics CEO Jennifer Jarrett buys $252,875 in shares By Investing.com - Investing.com UK","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiwAFBVV95cUxPOWdQWVhhZHJsa2plQXA2ZGZnTUlUZGROQ09sOTV3cUdDZFctT0hVTXc0alI3dmlkNGJqaEFjN19WT1NlcEhHUUM2alJodVVqQXNiaWd5YzV4dVl0S0Y4QWlJTlB2QjBDOWptSXY5TjJHRE9mUEk4ZFBaQ2RIRGJTaEFHRmtvNmJ0bWc0ekY4UE1DcENfbl9iQmxBZnNGQk9xdXhyM2hzbTR5NzY0STV3MlFWa3lONlFrZlJjeHFPMXE?oc=5","Mon, 28 Sep 2026 11:32:00 GMT","Damora Therapeutics CEO Jennifer Jarrett buys $252,875 in shares By Investing.com Investing.com UK","Investing.com UK",{"title":236,"link":237,"pubDate":238,"description":239,"source":240},"Damora Therapeutics Advances CALR-Targeted Antibody Into Early Clinical Testing - TipRanks","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiywFBVV95cUxNZS10Um5tZW5ZZE1aZGJ5cVZwNUE2TmNpS2lHMUp0WnJ4c2F0QjkwcmRhMjBXZ0FEd0VtZEIwVlFOd0lvaGR0X3Z2LVhpVVd6QXp5ZGNqZF9YSDZfOFNMUV8xSWFIS3VtSzlhWW9FT243UE1KTDBxUWwwdkVMMnJrYnZTNjNWdWpSYldYQUpEY1ExTlAyNy1LVXBjYS1QZkVTcXFQeks0ajZsaG9YMFdHaWFpeWNTSXp2cEw5aUdCRURuMC0tdGpPNDFQcw?oc=5","Wed, 30 Sep 2026 16:43:00 GMT","Damora Therapeutics Advances CALR-Targeted Antibody Into Early Clinical Testing TipRanks","TipRanks"]